# Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer

> **NCT01261299** · EARLY_PHASE1 · TERMINATED · sponsor: **University of California, Davis** · enrollment: 21 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Urinary Bladder Neoplasms

## Interventions

- **DRUG:** Carbon-14-labeled carboplatin

## Key facts

- **NCT ID:** NCT01261299
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Contract ended
- **Last updated:** 2018-01-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01261299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01261299, "Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01261299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*